Pfizer, Moderna, Novavax: executives from several US laboratories developing COVID-19 Vaccines have recently raked in millions of dollars by selling shares in their companies, raising questions about the advisability of such a move amid a national health crisis. On the same day that pharmaceutical giant Pfizer announced preliminary data showing …
Read More »A million dollar question arises when lab executives sell shares amid the race for the Covid-19 vaccine
